Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 17

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 17
---
public offering of (i) 5,620,000 units (the “Units”), with each Unit consisting of one share of common stock and one warrant
(the “Warrants”) and (ii) 380,000 pre-funded units (the “Pre-Funded Units”), with each Pre-Funded Unit consisting
of one pre-funded warrant and one Warrant. The underwriter also exercised its over-allotment option in part and purchased an additional
667,300 Warrants. The offering resulted in net proceeds of approximately $10.5 million, after deducting underwriting discounts and commissions
and other estimated offering expenses. Each Unit was sold to the public at a price of $2.00 per Unit and each Pre-Funded Unit was sold
to the public at a price of $1.999 per Pre-Funded Unit (which represents the public offering price of each Unit less the $0.0001 per share
nominal exercise price for each Pre-Funded Warrant). On August 8, 2025, the Warrants commenced trading on The Nasdaq Capital Market under
the symbol “BIVIW.” Each Warrant is immediately exercisable, entitles the holder to purchase one share of common stock at
an exercise price of $2.50 per share and expires five years from the date of issuance. Each Pre-Funded Warrant is immediately exercisable,
entitles the holder to purchase one share of common stock, and may be exercised at any time until exercised in full. Additionally,
upon closing, the Company issued the representative warrants to purchase 300,000 shares of Common Stock exercisable at a per share price
of $2.50, which was equal to 125% of the public offering price per share. The representative’s Warrants are exercisable during a
five-year period commencing 180 days from August 11, 2025.   

Stock Options

The following table summarizes the activity relating to the Company’s
stock options for the three months ended September 30, 2025:

    Schedule of summarizes the activity relating to the company’s stock options 

    Options  
    Weighted-Average Exercise Price  
    Weighted Remaining Average Contractual Term  
    Aggregate Intrinsic Value 
  
    Outstanding at June 30, 2025 
     84,872  
    $286.20  
     6.2  
    $- 
  
    Outstanding at September 30, 2025